Strata Skin Sciences Statistics
Want to see SSKN full AI Analyst Report?
Strata Skin Sciences (SSKN) Stock Statistics & Valuation Metrics
Total Valuation
Strata Skin Sciences has a market cap or net worth of $589.00. The enterprise value is $15.78M.
- Market Cap
- $589.00
- Enterprise Value
- $15.78M
Share Statistics
Strata Skin Sciences has 5,888,199 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 5,888,199
- Owned by Insiders
- 0.15%
- Owned by Institutions
- 16.74%
Financial Efficiency
Strata Skin Sciences’s return on equity (ROE) is -2.15 and return on invested capital (ROIC) is -30.14%.
- Return on Equity (ROE)
- -2.15
- Return on Assets (ROA)
- -0.21
- Return on Invested Capital (ROIC)
- -30.14%
- Return on Capital Employed (ROCE)
- -1.54
- Revenue Per Employee
- 269.26K
- Profits Per Employee
- -54.92K
- Employee Count
- 114
- Asset Turnover
- 1.01
- Inventory Turnover
- 4.55
Valuation Ratios
The current PE Ratio of Strata Skin Sciences is -0.00. Strata Skin Sciences’s PEG ratio is 0.00.
- PE Ratio
- -0.00
- PS Ratio
- 0.00
- PB Ratio
- 0.00
- Price to FCF
- -0.00
- Price to Operating Cash Flow
- -0.00
- PEG Ratio
- 0.00
Income Statement
In the last 12 months, Strata Skin Sciences had revenue of 30.70M and earned -6.26M in profits. Earnings per share was -1.35.
- Revenue
- 30.70M
- Gross Profit
- 17.88M
- Operating Income
- -5.83M
- Pretax Income
- -6.25M
- Net Income
- -6.26M
- EBITDA
- 177.00K
- Earnings Per Share (EPS)
- -1.35
Cash Flow
In the last 12 months, operating cash flow was -2.79M and capital expenditures -1.47M, giving a free cash flow of -4.26M billion.
- Operating Cash Flow
- -2.79M
- Free Cash Flow
- -4.26M
- Free Cash Flow per Share
- -0.60
Dividends & Yields
Strata Skin Sciences pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -755483.87%
- Earnings Yield
- -688325.92%
Stock Price Statistics
- Beta
- 9.50
- 52-Week Price Change
- -94.83%
- 50-Day Moving Average
- 0.13
- 200-Day Moving Average
- 0.63
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Important Dates
Strata Skin Sciences upcoming earnings date is Nov 17, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 19, 2026
- Next Earnings Date
- Nov 17, 2026
- Ex-Dividend Date
- ―
Financial Position
Strata Skin Sciences as a current ratio of 0.58, with Debt / Equity ratio of 559.42%
- Current Ratio
- 0.58
- Quick Ratio
- 0.48
- Debt to Market Cap
- 0.27
- Net Debt to EBITDA
- 47.21
- Interest Coverage Ratio
- -2.98
Taxes
In the past 12 months, Strata Skin Sciences has paid 12.00K in taxes.
- Income Tax
- 12.00K
- Effective Tax Rate
- -0.00
Enterprise Valuation
Strata Skin Sciences EV to EBITDA ratio is 108.53, with an EV/FCF ratio of -2.38.
- EV to Sales
- 0.35
- EV to EBITDA
- 108.53
- EV to Free Cash Flow
- -2.38
- EV to Operating Cash Flow
- -3.72
Balance Sheet
Strata Skin Sciences has $7.91M in cash and marketable securities with $16.27M in debt, giving a net cash position of -$8.36M billion.
- Cash & Marketable Securities
- $7.91M
- Total Debt
- $16.27M
- Net Cash
- -$8.36M
- Net Cash Per Share
- -$1.42
- Tangible Book Value Per Share
- -$0.32
Margins
Gross margin is 59.05%, with operating margin of -16.93%, and net profit margin of -16.97%.
- Gross Margin
- 59.05%
- Operating Margin
- -16.93%
- Pretax Margin
- -16.92%
- Net Profit Margin
- -16.97%
- EBITDA Margin
- 0.32%
- EBIT Margin
- -12.92%
Analyst Forecast
The average price target for Strata Skin Sciences is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -8.54%
- EPS Growth Forecast
- 40.91%
Scores
- Smart Score
- ―
- AI Score
- 43
